Healthcare Analytical Testing Services Market Report 2026

Healthcare Analytical Testing Services Market Overview

• Healthcare Analytical Testing Services market size has reached to $7.6 billion in 2025 • Expected to grow to $14.64 billion in 2030 at a compound annual growth rate (CAGR) of 13.9% • Growth Driver: Surge In Clinical Trials Drives Healthcare Analytical Testing Services Market Growth • Market Trend: Innovative Analytical Services Redefine The Healthcare Analytical Testing Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Healthcare Analytical Testing Services Market?

Healthcare analytical testing service refers to the process of validation of procedures used in drug discovery and development, finished products, and the detection of microorganisms in biological drugs, suspensions, and emulsions. The main types of healthcare analytical testing services are bioanalytical testing services, physical characterization services, method development and validation testing services, raw material testing services, batch-release testing services, stability testing, microbial testing services, and others. Bioanalytical testing services use medical devices to provide pharmacokinetics and pharmacodynamics aspects and determine drug and metabolite content in blood and urine used in pharmacological and toxicological research. Bioanalytical refers to the process of detection of metabolites in biological fluids. The different end users include pharmaceutical and biopharmaceutical companies, medical device companies, and clinical research organizations.

What Is The Healthcare Analytical Testing Services Market Growth Forecast?

The healthcare analytical testing services market size is expected to see rapid growth in the next few years. It will grow to $14.64 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to increasing adoption of ai-enabled lab analytics, rising demand for high-throughput testing services, expansion of personalized medicine development, growing focus on rapid microbial detection, increasing outsourcing of analytical validation. Major trends in the forecast period include increasing demand for advanced bioanalytical testing, rising adoption of automated laboratory systems, growing focus on regulatory-compliant validation services, expansion of outsourced analytical testing, enhanced integration of digital laboratory platforms.

Global Healthcare Analytical Testing Services Market Segmentation

1) By Type: Bioanalytical Testing Services, Physical Characterization Services, Method Development And Validation Testing Services, Raw Material Testing Services, Batch-Release Testing Services, Stability Testing, Microbial Testing Services 2) By Application: Drug Discovery And Preclinical Research, Clinical Trials (Phase I–III), Quality Control And Batch-Release Testing, Stability Studies And Shelf-Life Characterization, Regulatory Compliance And Submission Support, Manufacturing Process Support And Troubleshooting, Post-Market Surveillance And Pharmacovigilance Testing 3) By End User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Contract Research Organizations Subsegments: 1) By Bioanalytical Testing Services: Pharmacokinetics Testing, Biomarker Analysis 2) By Physical Characterization Services: Particle Size Analysis, Surface Area Analysis 3) By Method Development and Validation Testing Services: Analytical Method Development, Method Validation 4) By Raw Material Testing Services: Identity Testing, Purity Testing, 5) By Batch-Release Testing Services: Quality Control Testing, Compliance Testing 6) By Stability Testing: Accelerated Stability Testing, Long-Term Stability Testing 7) By Microbial Testing Services: Sterility Testing, Endotoxin Testing

What Is The Driver Of The Healthcare Analytical Testing Services Market?

The increasing number of clinical trials is expected to drive the growth of the healthcare analytical testing services market. Clinical trials are research studies conducted with human participants to evaluate the safety and efficacy of medical treatments or interventions. The increasing number of clinical trials is primarily driven by the rising prevalence of chronic and rare diseases, as these conditions create a growing demand for new and effective treatments. Healthcare analytical testing services are used in clinical trials for assessment of drug safety and efficacy, dosing and formulation, data integrity, and quality control. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, highlighted that the number of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, an increasing number of clinical trials is expected to propel the growth of the healthcare analytical testing services industry.

Key Players In The Global Healthcare Analytical Testing Services Market

Major companies operating in the healthcare analytical testing services market are Almac Group, ALS Limited, Anacura Life Sciences, Charles River Laboratories International Inc., Element Materials Technology Group, Eurofins Scientific SE, ICON plc, Impact Analytical Testing Lab, Intertek Group plc, Pace Analytical Services LLC, PPD Inc., SourceBio International plc, Steris Corporation, Syneos Health Inc., WuXi AppTec, Analytical Bio-Chemistry Laboratories, Avance Biosciences, Avista Pharma Solutions, Avomeen Analytical Services, BioPharma Services Inc., Boston Analytical, Laboratory Corporation, MedPharm Inc., Micro Quality Labs, Microbac Laboratories, Nelson Laboratories LLC, Pacific Biolabs Inc.

Global Healthcare Analytical Testing Services Market Trends and Insights

Major companies operating in the healthcare analytical testing services market are focusing on innovative services such as broad bioanalytical coverage for the comprehensive support of drug development from discovery through late stage clinical trials, including pharmacokinetic (PK) and pharmacodynamic (PD) assessments. Broad bioanalytical coverage refers to a bioanalytical service’s ability to handle a wide range of testing needs across multiple types of molecules and stages of drug development. For instance, in August 2024, SGS Life Science Services SA, a Switzerland based contract research organization (CRO) specializing in analytical development and quality control laboratory services, introduced a new bioanalytical testing lab, a specialized laboratory that measures drugs with their metabolites and other biologically relevant molecules in biological samples. Additionally, it offers cell based assays for cellular biomarkers and sensitive quantification.

What Are Latest Mergers And Acquisitions In The Healthcare Analytical Testing Services Market?

In September 2024, Pace Life Sciences, a US-based contract development, and manufacturing organization (CDMO), acquired Catalent Small Molecule Analytical services from Catalent for an undisclosed amount. This acquisition allows Pace to strengthen its capabilities as a full-service analytical outsourcing provider, particularly in supporting clients throughout the early stages of drug research and development to commercialization. Catalent is a US-based provider of analytical services for drug development.

Regional Outlook

North America was the largest region in the healthcare analytical testing services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Healthcare Analytical Testing Services Market?

The healthcare analytical testing services market includes revenues earned by providing services such as environmental monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Healthcare Analytical Testing Services Market Report 2026?

The healthcare analytical testing services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare analytical testing services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.